Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Koning
AddedFeb 15, 2024
UpdatedJun 18, 2026
Koning

Koning

Koning Corp., NY-based, pioneers in advanced 3D medical imaging systems for precise breast cancer detection.

HQ
Norcross, GA, US
Founded
2002
Overview
Compare
Fundraising
Employees
Website

Koning Corporation, based in New York, develops advanced medical imaging systems for breast cancer detection using cone-beam computed tomography technology. Their flagship product, the Koning Vera Breast CT, provides true 3D images for early and precise breast cancer detection, enhancing diagnostic accuracy and patient outcomes.

Koning has achieved significant milestones, including being a finalist for the Sharecare Award for Innovative Breast Imaging Technology. Their Vera Breast CT is now offered at Brookwood Baptist Hospital, showcasing their impact in the medical imaging field.

Koning - Similar Companies

Kjaya logo

Kjaya

Kineolabs logo

Kineolabs

kineolabs.com

Body Vision Medical logo

Body Vision Medical

Kereos logo

Kereos

Seno Medical Instruments logo

Seno Medical Instruments

senomedical.com

Advanced Fpat Imaging logo

Advanced Fpat Imaging

Dilon Technologies logo

Dilon Technologies

dilon.com

Koronis Biomedical Technologies logo

Koronis Biomedical Technologies

koronisbiotech.com

Clarisond logo

Clarisond

Gamma Medica-Ideas logo

Gamma Medica-Ideas

Clarix Imaging logo

Clarix Imaging

clariximaging.com

Malcova logo

Malcova

3D Intelligent Pathological Medical Image Solutions logo

3D Intelligent Pathological Medical Image Solutions

Kolo Medical logo

Kolo Medical

image32 logo

image32

Koning - Quick Facts

Who are Koning's competitors?

Companies similar to Koning include Kjaya, Kineolabs, Body Vision Medical and Kereos.

When was Koning founded?

Koning was founded in 2002.

Where is Koning's headquarters located?

Koning's headquarters is located in Norcross, GA, US.

When was Koning's last funding round?

Koning's most recent funding round was for $103.9k (USD) in August 2022.

How much has Koning raised to-date?

As of Aug 1, 2022, Koning has raised a total of $18.2M (USD).

How many employees does Koning have?

Koning has 36 employees as of Feb 4, 2024.

Koning - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • AI
  • Analytics
Geographic Exposure
  • United States
Revenue
  • Software
Main Product
  • Medical Imaging
Tags
  • Biotech
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified